FDA Approves Branded Bevacizumab for Wet AMD

Also Read

• Congressional Limits on Physician‑Owned Hospitals Safeguard Patient Safety
• Former FDA Official Blasts Trump Administration’s Cyclospora Outbreak Response as a Failure of Leadership
• Health Correspondents Examine Public Health Threats and Financial Pressures
• Addressing Pharmaceutical Costs: The Need for Greater Transparency and Improved Accessibility